CN Patent

CN105960397A — Cgrp-活性化合物的片剂制剂

Assigned to Merck Sharp and Dohme BV · Expires 2016-09-21 · 10y expired

What this patent protects

本发明涉及一种包含式I化合物或其盐(API)在水溶性聚合物基质中的挤出物或固体溶液的组合物，其中“R a ”独立地是‑H或‑F，所述组合物进一步包含崩解系统，其允许由其制备的片剂在待释放API的环境中快速崩解。

USPTO Abstract

本发明涉及一种包含式I化合物或其盐(API)在水溶性聚合物基质中的挤出物或固体溶液的组合物，其中“R a ”独立地是‑H或‑F，所述组合物进一步包含崩解系统，其允许由其制备的片剂在待释放API的环境中快速崩解。

Drugs covered by this patent

Patent Metadata

Patent number
CN105960397A
Jurisdiction
CN
Classification
—
Expires
2016-09-21
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.